Gilead Sciences Corporate Office - Corporate Office HQ

Gilead Sciences Corporate Office

How would you rate your experience with Gilead Sciences ?

[Total: 1    Average: 3/5]

Gilead Sciences Corporate Office Address

Gilead Sciences
333 Lakeside Dr
Foster City, CA 94404

Contact Gilead Sciences

Phone Number: (650) 574-3000
Fax Number: (650) 578-9264
Email: Email Gilead Sciences

Gilead Sciences Facts

Date Founded:
Founding Location:
Number of Employees:

Gilead Sciences Executives

CEO: John C. Martin
CFO: Robin L. Washington
COO: John F. Milligan

Gilead Sciences History

Gilead Sciences was founded by Michael Riordan in 1987 with a $2 million investment from Menlo Ventures.

The company focused on making small strands of DNA to assess the potential of gene therapy. Gilead Sciences developed small molecule antiviral therapeutics in 1991, one of which was tenofivir, which became one of the most widely-used anti AIDS drugs.

Donald Rumsfield became a board member at Gilead Sciences in 1988, and was the chairman in 2001 when he was stepped down to become the U.S. Secretary of Defense. At the time he owned between $5 million and $25 million of Gilead stock.

Today Gilead Sciences is a biotech company with treatments for hepatitis, HIV, infections related to AIDS, cardiovascular drugs, and respiratory and ophthalmic medicines.

Gilead Sciences is traded publicly on the NASDAQ under the ticker symbol GILD, is a member of the S&P 500, is #324 in the Fortune 500, has 6,100 employees, and had $17.44 billion in revenue in 2013.


Gilead Sciences FAQs

Question 1: What is the phone number for Gilead Sciences?
Answer 1: The phone number for Gilead Sciences is (650) 574-3000.

Question 2: Who is the CEO of Gilead Sciences?
Answer 2: The CEO of Gilead Sciences is John C. Martin.

Question 3: Who founded Gilead Sciences?
Answer 3: Gilead Sciences was founded by in .

{ 0 comments… add one now }

Leave a Comment

Want to make sure Gilead Sciences sees your comment or complaint?

Share your experience to get more attention.

Previous post:

Next post: